Previous studies have shown that therapeutic inhibition of TREM-1 can blunt excessive inflammatory cell infiltration, resulting in a decreased severity of liver injury [30] and abdominal aortic aneurysm [28]. This evidence concerns the gene TREM1 and abdominal aortic aneurysm.